Voltarol 140 mg النرويج - النرويجية - Statens legemiddelverk

voltarol 140 mg

glaxosmithkline consumer healthcare a/s (1) - diklofenaknatrium - medisinert plaster - 140 mg

Zantac 150 mg النرويج - النرويجية - Statens legemiddelverk

zantac 150 mg

glaxosmithkline as - ranitidinhydroklorid - brusetablett - 150 mg

Zantac 25 mg/ ml النرويج - النرويجية - Statens legemiddelverk

zantac 25 mg/ ml

glaxosmithkline as - ranitidinhydroklorid - injeksjonsvæske, oppløsning - 25 mg/ ml

Zantac 150 mg النرويج - النرويجية - Statens legemiddelverk

zantac 150 mg

glaxosmithkline as - ranitidinhydroklorid - tablett - 150 mg

Zovirax 800 mg النرويج - النرويجية - Statens legemiddelverk

zovirax 800 mg

glaxosmithkline as - aciklovir - tablett - 800 mg

Zovirax 80 mg/ ml النرويج - النرويجية - Statens legemiddelverk

zovirax 80 mg/ ml

glaxosmithkline as - aciklovir - mikstur, suspensjon - 80 mg/ ml

Zovirax 200 mg النرويج - النرويجية - Statens legemiddelverk

zovirax 200 mg

glaxosmithkline as - aciklovir - tablett - 200 mg

Zovirax 30 mg/ g النرويج - النرويجية - Statens legemiddelverk

zovirax 30 mg/ g

glaxosmithkline as - aciklovir - Øyesalve - 30 mg/ g

Zyban 150 mg النرويج - النرويجية - Statens legemiddelverk

zyban 150 mg

glaxosmithkline as - bupropionhydroklorid - depottablett - 150 mg

Arexvy الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

arexvy

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratorisk syncytialvirusinfeksjoner - vaksiner - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.